Cel-Sci deal

CELI (Alexandria, Va.) signed a letter of intent with the Dr. L. Willems Instituut (Belgium) to license exclusive worldwide rights to T cell vaccination, a potential multiple sclerosis (MS) treatment. CELI will fund further R&D and a Phase II/III trial involving about 100 patients, expected to begin in mid-year. ...